Condition (MeSH)
Anemia, Macrocytic
ClinicalTrials.gov lists 8 trials for Anemia, Macrocytic or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 8 trials are tagged with Anemia, Macrocytic itself; the rest are tagged with a narrower condition beneath it.
When did Anemia, Macrocytic trials start? (7)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2017 | 1 |
| 1995 | 1 |
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 8 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Anemia, Macrocytic trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
| Not applicable | 2 |
| Observational | 5 |
How many Anemia, Macrocytic trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Anemia, Macrocytic trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Faculty Hospital Kralovske Vinohrady | 1 |
| Momentum Data | 1 |
Which publications cover Anemia, Macrocytic? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Diagnosis, Treatment and Prevention of Nutritional Anemia in Children: Recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics. | Indian pediatrics | 2022 | Yes |
| Constitutional Trisomy 8 Mosaicism with Persistent Macrocytosis. | Cytogenetic and genome research | 2016 | Yes |
| Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome. | Blood | 2013 | Yes |
| Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation. | Leukemia research | 2011 | Yes |
| Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends. | Expert review of hematology | 2017 | No |
Showing 5 of 9 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.